Jason Aryeh, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 20,000 shares at $170.41 ($3.4M) on 2025-09-23, disclosed to the SEC on 2025-09-24.
Open-market sale of $3.4M LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $170.41 | 4,418 | $753K | 22.0% |
| 2 | $170.41 | 4,418 | $753K | 22.0% |
| 3 | $170.96 | 4,628 | $791K | 23.2% |
| 4 | $170.96 | 4,628 | $791K | 23.2% |
| 5 | $171.92 | 954 | $164K | 4.8% |
| 6 | $171.92 | 954 |
| $164K |
| 4.8% |
| Total | $170.81 avg | 20,000 | $3.4M | 100% |
| Filing → |
| OBIO | BUY | 2026-05-19 | $35K | — | Filing → |
| OBIO | BUY | 2025-09-19 | $2K | — | Filing → |
| LGND | BUY | 2019-09-04 | $131K | — | Filing → |